Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Eurofins Biopharma Product Testing Sweden AB

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 2021/12
Turnover 67,508 Less Arrow 61,765 Less Arrow 56,116
Financial expenses 2,592 Less Arrow 1,675 Less Arrow 1,157
Earnings before taxes -20,374 Less Arrow -21,022 Less Arrow -23,168
EBITDA -12,940 Less Arrow -14,342 Less Arrow -16,893
Total assets 36,643 More Arrow 46,159 More Arrow 61,324
Current assets 21,057 More Arrow 26,015 More Arrow 42,209
Current liabilities 21,816 Less Arrow 13,888 More Arrow 13,937
Equity capital -18,668 More Arrow 1,668 More Arrow 18,560
- share capital 100 Equal arrow 100 Equal arrow 100
Employees (average) 46 More Arrow 50 More Arrow 60

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency -50.9% More Arrow 3.6% More Arrow 30.3%
Turnover per employee 1,468 Less Arrow 1,235 Less Arrow 935
Profit as a percentage of turnover -30.2% Less Arrow -34.0% Less Arrow -41.3%
Return on assets (ROA) -48.5% More Arrow -41.9% More Arrow -35.9%
Current ratio 96.5% More Arrow 187.3% More Arrow 302.9%
Return on equity (ROE) 109.1% Less Arrow -1260.3% More Arrow -124.8%
Change turnover 5,743 Less Arrow 5,649 Less Arrow -4,651
Change turnover % 9% More Arrow 10% Less Arrow -8%
Chg. No. of employees -4 Less Arrow -10 More Arrow 8
Chg. No. of employees % -8% Less Arrow -17% More Arrow 15%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.